Immunotherapy as an emerging cancer treatment method, has shown great potential in the treatment of osteosarcoma, and the association between PD-1/PD-L1 inhibitors and the NF - κ B signaling pathway has attracted much attention. This evidence concerns the gene CD274 and osteosarcoma.